The first Strongbridge Biopharma plc trade was made in Q1 2018.
Since then Ken Griffin bought shares four more times and sold shares on six occasions. The investor completely sold their stake between Q2 2021 and Q3 2021.
Avg closing price
Price range
Sold -19.5 Thousand shares
Q3 2021
Avg closing price
$2.33
Price range
$1.89
-
$3.08
Sold 8.7% shares (-1.87 Thousand shares)
Q2 2021
Avg closing price
$2.64
Price range
$2.27
-
$3.15
New holding (+21.4 Thousand shares)
Q1 2021
Avg closing price
$3.02
Price range
$2.46
-
$3.96
Sold -37.6 Thousand shares
Q3 2020
Avg closing price
$3.37
Price range
$2.10
-
$4.24
Sold 69.7% shares (-86.7 Thousand shares)
Q2 2020
Avg closing price
$3.00
Price range
$1.74
-
$4.40
Increased shares by 722.4% (+109 Thousand shares)
Q1 2020